Mas Pharmaceutical Industries Jordan

What Mas Pharmaceutical Industries Jordan does

Mas Pharmaceutical Industries is a privately held pharmaceutical manufacturer headquartered in Amman, Jordan, specializing in cephalosporin antibiotics. The company operates a manufacturing facility on a 10,000 m2 land parcel with 5,000 m2 of built area, equipped with globally imported machines and devices described as matching international specifications and representing the first stage of manufacturing. Its product portfolio is concentrated entirely in the cephalosporin class across four dosage forms: tablets, capsules, dry syrup (dry suspension), and sterile filled vials. The company states a production capacity of more than one million boxes of medicine per month.

The business model is a conventional pharma manufacturing and distribution model: products are sold through direct distribution to healthcare providers, hospitals, clinics, and pharmacies, with stated geographic reach across the Middle East, GCC, North Africa, and Asia. The company positions itself on compliance with WHO, the Arab Organization for Drug, and the Jordanian FDA (JFDA), and frames its value proposition around affordable prices and quality-assured cephalosporin supply. The stated strategic intent is to become the brand of choice for cephalosporins in the region and to entry advanced international markets over time.

The company is very small relative to its stated capacity: only 13 employees, no disclosed parent or subsidiary, no public funding history, no disclosed distributor or licensor partnerships, no named end customers, and no patents or trademarks in the available data. Active job postings for sterile-area production technicians, engineering and maintenance trainees, and QC analysts indicate the operation is still scaling. There is no information on revenue, ownership structure, or management team beyond general contact details.

Name

Mas Pharmaceutical Industries Jordan

Legal name

MAS Pharmaceutical Industries

Website

https://maspharma.org

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

Mas Pharmaceutical Industries is a Jordan-based pharmaceutical manufacturer specializing in cephalosporin antibiotics in tablet, capsule, dry syrup, and sterile vial forms. Producing over 1 million boxes monthly, it supplies healthcare providers across the Middle East, GCC, North Africa, and Asia.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Infectious Disease & Antimicrobials Pharmaceuticals (HLAIAAAG)

akta.pro secondary industries

Primary Pharmaceutical Packaging (Blister Packs, Bottles, Vials, Ampoules) (IMALAIAA), Parenteral & Injectable Packaging Components (Stoppers, Seals, Syringes, Cartridges) (IMALAIAE), Sterile & Aseptic Medical Packaging (Pouches, Wraps, Sterile Barriers) (IMALAIAB)

Keywords

• Cephalosporin antibiotics
• Pharmaceutical manufacturing
• Generic antibiotics
• Sterile injectable vials
• Dry syrup suspension

Headquarters

HQ city

Amman

HQ country

Jordan

HQ region

Middle East

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Personnel, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Pharmaceutical Product Sales: The company generates revenue through the manufacturing and sale of cephalosporin antibiotic products in various forms (Dry Syrup, tablets, capsules, and vials). Products are distributed across Middle East, GCC, North Africa, and Asia markets.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

Mas Pharmaceutical Industries manufactures cephalosporin antibiotics at a facility in Amman, Jordan, producing over one million boxes of medicine monthly. The portfolio spans four dosage forms — tablets, capsules, dry syrup suspension, and sterile filled vials — designed to address bacterial infection treatment needs for healthcare providers and patients across the Middle East, GCC, North Africa, and Asia.

Product overview

Mas Pharmaceutical Industries is a pharmaceutical manufacturer specializing in cephalosporin antibiotics, producing over a million boxes of medicine monthly. The company offers four distinct product lines: Cephalosporin Tablet, Cephalosporin Filled Vials, Cephalosporins Dry Suspension, and Cephalosporin Capsules. These products cover multiple dosage forms (tablets, capsules, vials, and dry syrup) to serve different patient needs and administration preferences within the cephalosporin antibiotic category.

Differentiator

Problem solved

Functional benefit

Products and services

• Cephalosporin Tablet Tablet form of cephalosporin antibiotic medication produced by Mas Pharmaceutical Industries, intended for healthcare providers and pharmacies treating bacterial infections.
• Cephalosporin Filled Vials Sterile injectable vials containing cephalosporin antibiotic solution, produced by Mas Pharmaceutical Industries for hospital and clinical use in bacterial infection treatment.
• Cephalosporins Dry Suspension Dry syrup suspension form of cephalosporin antibiotic for reconstitution prior to administration, manufactured by Mas Pharmaceutical Industries for healthcare providers and pharmacies.
• Cephalosporin Capsules Capsule form of cephalosporin antibiotic medication produced by Mas Pharmaceutical Industries for use by healthcare providers and pharmacies treating bacterial infections.

Quantifiable outcome

• Over 1 million boxes of medicine produced monthly

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Regional players

• Julphar (Gulf Pharmaceutical Industries): UAE-based pharmaceutical manufacturer with a broad generics portfolio serving the GCC and wider MENA region. Comparable as a regional generic pharma manufacturer competing in similar antibiotic categories across overlapping geographies.
• EIPICO (Egyptian International Pharmaceutical Industries Company): Major Egyptian generic pharmaceutical manufacturer with antibiotics and broad therapeutic coverage serving MENA. Comparable as a regional generics manufacturer with similar product categories and Middle East/North Africa distribution.
• Pharma 5: Moroccan pharmaceutical manufacturer producing generics including antibiotics for North African markets. Comparable as a regional antibiotic manufacturer competing for North African government tenders.
• SPIMACO (Saudi Pharmaceutical Industries & Medical Appliances): Saudi Arabia's largest pharmaceutical manufacturer producing generics including antibiotics. Comparable as a regional incumbent in GCC pharmaceutical manufacturing with overlap in MENA generic antibiotic markets.

Broad incumbents

• Teva Pharmaceutical Industries: World's largest generic drug manufacturer with antibiotics and broad therapeutic coverage. Comparable as a broad incumbent in generic pharmaceuticals competing for the same regional procurement contracts.
• Sandoz (Novartis): Global leader in off-patent medicines including generic antibiotics. Comparable as a broad incumbent with cephalosporin products competing across the same target markets, though at a much larger scale.

Emerging players

• Cipla: Indian-headquartered global pharmaceutical company with a strong antibiotics and respiratory portfolio. Comparable as an emerging global generic manufacturer with overlap in cephalosporin categories and emerging-market distribution.
• Aurobindo Pharma: Large Indian generics manufacturer with a substantial cephalosporin and sterile injectable portfolio. Comparable as a cost-competitive cephalosporin producer competing in the same global generic antibiotic category.

Direct peers

• Hikma Pharmaceuticals: Jordan-headquartered multinational pharmaceutical company with a broad generics portfolio including injectable cephalosporins. Comparable as a Jordan-based pharma manufacturer serving MENA and global markets, with overlapping cephalosporin capabilities.
• Dar Al Dawa: Jordanian pharmaceutical manufacturer producing antibiotics and generics for regional and export markets. Direct comparable as a Jordan-based antibiotic/generics producer with overlapping MENA distribution footprint.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/mas-pharmaceutical-industries-jordan

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mas Pharmaceutical Industries Jordan